cDPI: Line extension with capsule-based inhalation drug delivery

Today, there are clear signs that the biopharmaceutical industry is facing a quiet yet potentially damaging force: compressive disruption. However, future-focused biopharma companies have found a way to deliver exceptional growth amidst compressive disruption: by embracing New Science, an ever-evolving combination of the best in science and health technology that is filling unmet need and raising the standard of care. Accenture research finds that leaders in New Science are investing 6-7x more in digital, data and genomics compared to their peers.

Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to market.

Individuals take for granted everyday interactions with well-designed products and devices that save both time and aggravation. Well-designed products can eliminate overall confusion for the user. Every day, more medical devices are designed for portability and at home monitoring. A major initiative in the medical device industry is to reduce the workload on our already overworked medical professionals. Medical device manufacturers must consider countless items when designing and manufacturing their final product, but unfortunately, connectors usually take a back seat to other more engaging topics. Nicomatic has relationships with many of the top medical device manufacturers to help them determine the best connector solution for their specific application. In the medical market, connectors are unique to their specific application and one solution does not work across the board.

Large-scale Production of Biologics is susceptible to microbial contamination because many manufacturing steps occur under non-sterile conditions in aqueous systems at ambient temperature or 2-8 °C under substantially neutral pH conditions. Regardless of where in the Drug Substance (DS) manufacture (manufacture of the Active Pharmaceutical Ingredient), or Drug Product (DP) manufacture (manufacture of the Final Drug, e.g. formulated mAbs filled in vials or syringes) they occur, microbial contaminations can have a significant impact on product quality and patient safety.